The global flow cytometry market is projected to grow from USD 5.06 billion in 2025 to USD 9.85 billion by 2033, registering a CAGR of 8.7% during the forecast period, according to a recent market research report published by MarketsandMarkets™.
The report highlights increasing adoption of advanced cell analysis technologies across cancer diagnostics, immunology research, stem cell research, pharmaceutical research, biotechnology research, and clinical diagnostics as a major factor supporting growth of the global flow cytometry industry.
Rising demand for flow cytometry analyzers, cell sorters, flow cytometry consumables, flow cytometry reagents, antibodies, assays, kits, and flow cytometry software across hospitals and diagnostic laboratories, academic research institutes, pharmaceutical companies, and biotechnology companies is further contributing to market expansion.
Access key market insights and highlights from the report
brochure:
Download
Report Brochure
The growing use of clinical flow cytometry and research flow cytometry technologies for immunophenotyping, biomarker detection, hematology diagnostics, fluorescence cell analysis, and multiparametric cell analysis continues to strengthen market adoption globally.
The study evaluates the market across multiple segments, including:
- Technology
- Product & service
- Application
- End user
- Region
According to the report, the consumables segment accounted for the largest share of the flow cytometry market in 2023 due to recurring usage of reagents, antibodies, assays, and kits in routine laboratory workflows and research applications.
The cell-based flow cytometry segment accounted for a major share of the technology segment due to increasing use in cancer research, immunology research, and clinical diagnostics applications.
Based on applications, research applications accounted for the largest share of the market in 2023, supported by increasing investments in life sciences research, biomarker analysis, and single-cell analysis technologies.
Hospitals and diagnostic laboratories represent a significant share of the end-user segment due to rising use of advanced cytometry solutions in clinical diagnostics and disease monitoring applications.
The report identifies several major factors driving growth of the global cell analysis market:
- Increasing prevalence of cancer and infectious diseases
- Growing demand for precision medicine and personalized therapies
- Rising adoption of flow cytometry in clinical diagnostics
- Expanding applications in stem cell research and immunology research
- Increasing pharmaceutical and biotechnology R&D investments
- Technological advancements in high-throughput cellular analysis
- Growing focus on biomarker detection technologies
The report also provides detailed insights into:
- Market forecasts through 2033
- Regional revenue analysis
- Competitive landscape assessment
- Product portfolio benchmarking
- Pricing analysis
- Regulatory landscape
- Strategic partnerships and collaborations
- Product launches and technological advancements
Key Players Featured in the Report
The report profiles leading companies operating in the flow cytometry market, including:
- Becton, Dickinson and Company (BD)
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Miltenyi Biotec
- Sony Biotechnology Inc.
- Cytek Biosciences
- Enzo Biochem, Inc.
North America accounted for the largest share of the global flow cytometry market in 2023 due to established healthcare infrastructure, growing research funding, and increasing adoption of advanced diagnostic technologies. Asia Pacific is expected to witness significant growth during the forecast period driven by expanding biotechnology research activities and increasing healthcare investments.
As demand for cell characterization technologies, clinical diagnostics, single-cell analysis, and advanced cellular analysis technologies continue to increase, flow cytometry solutions are expected to remain a critical component of the global life sciences and diagnostics ecosystem.
Connect with the research team for customized insights,
regional analysis, enterprise-specific requirements, or analyst consultation:
Request
Inquiry / Speak to Analyst
Explore Related Flow Cytometry and Cell Analysis Market Reports
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/